AK

Arthur F. Kluge

BS Bristol-Myers Squibb: 28 patents #139 of 3,969Top 4%
S( Syntex (U.S.A.): 17 patents #17 of 599Top 3%
KT Kymera Therapeutics: 13 patents #5 of 23Top 25%
MI Mitobridge: 12 patents #2 of 40Top 5%
SS Salk Institute For Biological Studies: 7 patents #56 of 521Top 15%
AT Avilar Therapeutics: 4 patents #9 of 13Top 70%
GA Gpc Biotech Ag: 3 patents #6 of 42Top 15%
FT Forma Therapeutics: 2 patents #52 of 86Top 65%
AA Agennix Ag: 1 patents #12 of 17Top 75%
FT Forma Tm: 1 patents #20 of 24Top 85%
CP Cubist Pharmaceuticals: 1 patents #70 of 120Top 60%
📍 Watertown, MA: #3 of 1,634 inventorsTop 1%
🗺 Massachusetts: #337 of 88,656 inventorsTop 1%
Overall (All Time): #18,654 of 4,157,543Top 1%
88
Patents All Time

Issued Patents All Time

Showing 1–25 of 88 patents

Patent #TitleCo-InventorsDate
12258341 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Matthew Weiss, Yi Zhang, Xiaozhang Zheng 2025-03-25
12168057 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Matthew Weiss, Yi Zhang 2024-12-17
12071433 HMOX1 inducers Margaret Biddle, Sanjita Sasmal, Bharat Lagu, Xinyuan Wu, Takashi Ogiyama +1 more 2024-08-27
12006329 Protein degraders and uses thereof Nello Mainolfi, Nan Ji 2024-06-11
11993585 Poly-ADP ribose polymerase (PARP) inhibitors Taisuke Takahashi, Bharat Lagu, Nan Ji 2024-05-28
11932635 CRBN ligands and uses thereof Nello Mainolfi, Nan Ji 2024-03-19
11897882 Tricyclic crbn ligands and uses thereof Nan Ji, Matthew Weiss, Yi Zhang 2024-02-13
11807636 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Matthew Weiss, Yi Zhang, Xiaozhang Zheng 2023-11-07
11723980 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Matthew Weiss, Yi Zhang 2023-08-15
11578052 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Michael Downes, Ronald M. Evans, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi +4 more 2023-02-14
11512080 CRBN ligands and uses thereof Nello Mainolfi, Nan Ji 2022-11-29
11485743 Protein degraders and uses thereof Nello Mainolfi, Nan Ji 2022-11-01
11352350 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Matthew Weiss, Yi Zhang, Xiaozhang Zheng 2022-06-07
11351168 2,4-disubstituted pyrimidines useful as kinase inhibitors Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Hormoz Mazdiyasni, William Frederick Westlin, III +2 more 2022-06-07
11292792 Tricyclic CRBN ligands and uses thereof Nan Ji, Matthew Weiss, Yi Zhang 2022-04-05
11117889 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Matthew Weiss, Yi Zhang, Xiaozhang Zheng 2021-09-14
11034670 Poly-ADP ribose polymerase (PARP) inhibitors Taisuke Takahashi, Bharat Lagu, Nan Ji 2021-06-15
10968172 USP30 inhibitors Bharat Lagu, Pranab Maiti, Sunil Kumar Panigrahi 2021-04-06
10906885 PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof Michael Downes, Ronald M. Evans, Bharat Lagu, Masanori Miura, Sunil Kumar Panigrahi +4 more 2021-02-02
10874743 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Matthew Weiss, Yi Zhang 2020-12-29
10828300 Substituted 2,4-diaminopyrimidines as kinase inhibitors Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Hormoz Mazdiyasni, William Frederick Westlin, III +2 more 2020-11-10
10766888 HMOX1 inducers Margaret Biddle, Sanjita Sasmal, Bharat Lagu, Xinyuan Wu, Takashi Ogiyama +1 more 2020-09-08
10662195 Protein kinase conjugates and inhibitors Juswinder Singh, Russell C. Petter, Deqiang Niu, Lixin Qiao, Roy Lobb +2 more 2020-05-26
10611790 Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases Nan Ji 2020-04-07
10596172 2,4-disubstituted pyrimidines useful as kinase inhibitors Juswinder Singh, Russell C. Petter, Richland Wayne Tester, Hormoz Mazdiyasni, William Frederick Westlin, III +2 more 2020-03-24